Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Microbial Pathogenesis|August 11, 2025
Implementation of a post-exposure tularemia treatment model for pneumonic challenged Fischer ratsKevin D Mlynek, J Matthew Meinig, Melissa Teague, et al.
Human Vaccines & Immunotherapeutics|June 8, 2023
Functional assays to screen and select monoclonal antibodies that targetSergei S Biryukov, Nathaniel O Rill, Christopher P Klimko, et al.
Frontiers in Immunology|September 13, 2021
Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V VaccineSergei Biryukov, Jennifer L Dankmeyer, Zain Shamsuddin, et al.
Frontiers in Immunology|July 10, 2025
Immune responses following DNA vaccination by needle-free injection against Burkholderia pseudomallei hemolysin co-regulated protein 1Michael L Davies, Sergei S Biryukov, Christopher P Klimko, et al.
Vaccines|November 27, 2021
Predictive and Experimental Immunogenicity of Burkholderia Collagen-like Protein 8-Derived AntigensMegan E Grund, Eliza Kramarska, Soo Jeon Choi, et al.
Frontiers in Immunology|July 7, 2025
Comparison of homologous and heterologous vaccination strategies for combating disease caused by Burkholderia pseudomalleiSergei S Biryukov, Christopher K Cote, Christopher P Klimko, et al.
The Journal of Infectious Diseases|July 23, 2020
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With CiprofloxacinNicholas J Vietri, Steven A Tobery, Donald J Chabot, et al.
Frontiers in Microbiology|May 10, 2021
Proteomic Analysis of Non-human Primate Peripheral Blood Mononuclear Cells During Burkholderia mallei Infection Reveals a Role of Ezrin in Glanders PathogenesisChih-Yuan Chiang, Yang Zhong, Michael D Ward, et al.
Plos One|February 25, 2017
Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 miceJeremy J Bearss, Melissa Hunter, Jennifer L Dankmeyer, et al.
Plos One|July 2, 2024
Characterization of two affinity matured Anti-Yersinia pestis F1 human antibodies with medical countermeasure potentialNileena Velappan, Sergei S Biryukov, Nathaniel O Rill, et al.
Pageof 11